Gadolinium-enhanced MRI is useful as enhancement decreases markedly after treatment in patients in complete remission but not in patients with relapse.
In our previous experience using dynamic gadolinium-enhanced study in nine myeloma patients showed that contrast enhancement decreased in all six patients who responded to treatment but not in two of three who did not[ 28 ].
Afterwards the enhancement decreases gradually.
Meanwhile, the degree of enhancement decreases with increasing crosslink density.
The late gadolinium enhancement decreased on follow up CMR performed at 10 months.
The maximal light enhancement decreases with the width-to-depth ratio for both kinds of scratches.
However, the enhancement decreases with higher annealing temperature and prolonged annealing.
The MRI contrast enhancement decreased with increasing Eu doping concentration due to the replacement of the gadolinium atoms with Eu.
However, with further increasing in MgO thickness, PL enhancement decreases sharply because of the evanescent wave nature of LSP.
It is found that the thermal conductivity enhancement decreases with elapsed time for DNP-EG nanofluid when pH is 7.0.
